Trial intelligence / Profile preview

N-Acetylcysteine and Vitamins in Geriatric TBI

NCT04291066Phase 2Completed

Sponsor
HonorHealth Research Institute
Start
Sep 2019
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of acetylcysteine in traumatic brain injury (TBI) (2 arms), sponsored by HonorHealth Research Institute. Primary endpoint: Rivermead Post-concussion Questionnaire. Started Sep 2019; status: completed.

02

Drugs

acetylcysteine
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT04291066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04291066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call